The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
The Life History of 21 Breast Cancers
Open accessAbstract
Cancer evolves dynamically as clonal expansions supersede one another driven by shifting selective pressures, mutational processes, and disrupted cancer genes. These processes mark the genome, such that a cancer's life history is encrypted in the somatic mutations present. We developed algorithms to decipher this narrative and applied them to 21 breast cancers. Mutational processes evolve across a cancer's lifespan, with many emerging late but contributing extensive genetic variation. Subclonal diversification is prominent, and most mutations are found in just a fraction of tumor cells. Every tumor has a dominant subclonal lineage, representing more than 50% of tumor cells. Minimal expansion of these subclones occurs until many hundreds to thousands of mutations have accumulated, implying the existence of long-lived, quiescent cell lineages capable of substantial proliferation upon acquisition of enabling genomic changes. Expansion of the dominant subclone to an appreciable mass may therefore represent the final rate-limiting step in a breast cancer's development, triggering diagnosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cancer whole genome sequencing (WGS) is now feasible, with thousands of matched tumor-normal pairs successfully sequenced to date, revealing novel biological insights2–4.”
From Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study (2019) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
A map of human genome variation from population-scale sequencing.
The 1000 Genomes Project Consortium (2010) · Nature · doi:10.1038/nature09534 · Cited by 7,877
The landscape of somatic copy-number alteration across human cancers
Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Howie, B. N., Donnelly, P., & Marchini, J. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000529 · Cited by 3,928
Stratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,625
Self-citationCancer stem cells in solid tumours: accumulating evidence and unresolved questions
Visvader, J. E., & Lindeman, G. J. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2499 · Cited by 3,501
Patterns of somatic mutation in human cancer genomes
Greenman, C. D., Stephens, P., Smith, R., Dalgliesh, G. L., Hunter, C., Bignell, G. R., Davies, H. R., Teague, J. W., Butler, A. P., Stevens, C., et al. (2007) · Nature · doi:10.1038/nature05610 · Cited by 3,143
Self-citationTumour evolution inferred by single-cell sequencing
Navin, N., Kendall, J., Troge, J., Andrews, P., Rodgers, L., McIndoo, J., Cook, K., Stepansky, A., Levy, D., Esposito, D., et al. (2011) · Nature · doi:10.1038/nature09807 · Cited by 2,598
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
Flagged first, then by citations
1 of the 39 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- 1000 Genomes Project Consortium. (2010). A map of human genome variation from population-scale sequencing. Nature 467, 1061–1073. · DOI · Paper page
- Greenman, C.D., Pleasance, E.D., Newman, S., Yang, F., Fu, B., Nik-Zainal, S., Jones, D., Lau, K.W., Carter, N., Edwards, P.A., et al. (2012). Estimation of rearrangement phylogeny for cancer genomes. Genome Res. 22, 346–361. · DOI
- Van Loo, P., Nordgard, S.H., Lingjærde, O.C., Russnes, H.G., Rye, I.H., Sun, W., Weigman, V.J., Marynen, P., Zetterberg, A., Naume, B., et al. (2010). Allele-specific copy number analysis of tumors. Proc. Natl. Acad. Sci. USA 107, 16910–16915. · DOI
Cited by
Sorted by citations
Items 301–400 of 1,000
BitPhylogeny: a probabilistic framework for reconstructing intra-tumor phylogenies
Yuan, K., Sakoparnig, T., Markowetz, F. M., & Beerenwinkel, N. (2015) · Genome biology · doi:10.1186/s13059-015-0592-6 · Cited by 119
Inferring parsimonious migration histories for metastatic cancers
El-Kebir, M., Satas, G., & Raphael, B. J. (2018) · Nature Genetics · doi:10.1038/s41588-018-0106-z · Cited by 117
Single-cell mutational profiling and clonal phylogeny in cancer
Potter, N. E., Ermini, L., Papaemmanuil, E., Cazzaniga, G., Vijayaraghavan, G., Titley, I., Ford, A., Campbell, P., Kearney, L., & Greaves, M. (2013) · Genome Research · doi:10.1101/gr.159913.113 · Cited by 107
Self-citationCai, H., Kumar, N., Bagheri, H. C., von Mering, C., Robinson, M. D., & Baudis, M. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-82 · Cited by 111
KLF6-SV1 Drives Breast Cancer Metastasis and Is Associated with Poor Survival
Hatami, R., Sieuwerts, A. M., Izadmehr, S., Yao, Z., Qiao, R., Papa, L., Look, M. P., Smid, M., Ohlseen, J., Levine, A. C., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3004688 · Cited by 117
Self-citationThe Genomic and Immune Landscapes of Lethal Metastatic Breast Cancer
Mattos‐Arruda, L. D., Sammut, S., Ross, E. M., Bashford-Rogers, R. J. M., Greenstein, E., Markus, H., Morganella, S., Teng, Y. H. F., Maruvka, Y. E., Pereira, B., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.04.098 · Cited by 117
Self-citationPan-cancer analysis of whole genomesPreprint
Campbell, P. J., Getz, G., Stuart, J. M., Korbel, J. O., & Stein, L. D. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/162784 · Cited by 117
Self-citationZafar, H., Navin, N. E., Chen, K., & Nakhleh, L. K. (2019) · Genome Research · doi:10.1101/gr.243121.118 · Cited by 113
Chae, Y. K., Davis, A. A., Carneiro, B. A., Chandra, S., Mohindra, N., Kalyan, A., Kaplan, J., Matsangou, M., Pai, S., Costa, R., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11692 · Cited by 110
Classical pathology and mutational load of breast cancer – integration of two worlds
Budczies, J., Bockmayr, M. L., Denkert, C., Klauschen, F., Lennerz, J. K., Győrffy, B., Dietel, M., Loibl, S., Weichert, W., & Stenzinger, A. (2015) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.25 · Cited by 114
The impact of intra-clonal heterogeneity on the treatment of multiple myeloma
Brioli, A., Melchor, L., Cavo, M., & Morgan, G. J. (2014) · British Journal of Haematology · doi:10.1111/bjh.12805 · Cited by 116
Karlsson, A., Jönsson, M., Lauss, M., Brunnström, H., Jönsson, P., Borg, Å., Jönsson, G. B., Ringnér, M., Planck, M., & Staaf, J. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1087 · Cited by 112
Self-citationMutational History of a Human Cell Lineage from Somatic to Induced Pluripotent Stem Cells
Rouhani, F. J., Nik‐Zainal, S., Wüster, A., Li, Y., Conte, N., Koike-Yusa, H., Kumasaka, N., Vallier, L., Yusa, K., & Bradley, A. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1005932 · Cited by 113
Self-citationSaliva-Exosomics in Cancer: Molecular Characterization of Cancer-Derived Exosomes in Saliva
NONAKA, T., & Wong, D. T. (2017) · The Enzymes · doi:10.1016/bs.enz.2017.08.002 · Cited by 118
APOBEC3 genes: retroviral restriction factors to cancer drivers
Henderson, S. R., & Fenton, T. R. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.02.007 · Cited by 107
Genome evolution during progression to breast cancerPreprint
Newburger, D. E., Kashef-Haghighi, D., Weng, Z., Salari, R., Sweeney, R. T., Brunner, A. L., Zhu, S., Guo, X., Varma, S., Troxell, M. L., et al. (2013) · Genome Research · doi:10.1101/gr.151670.112 · Cited by 108
EMu: probabilistic inference of mutational processes and their localization in the cancer genome
Fischer, A., Illingworth, C. J. R., Campbell, P. J., & Mustonen, V. (2013) · Genome biology · doi:10.1186/gb-2013-14-4-r39 · Cited by 105
Self-citationMorris, Q., Liu, P., Woloszynska‐Read, A., Zhang, J., Luo, W. F., Qin, M., Bshara, W., Conroy, J. M., Sabatini, L. M., Vedell, P. T., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313580111 · Cited by 107
Hajirasouliha, I., Mahmoody, A., & Raphael, B. J. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu284 · Cited by 106
Processed pseudogenes acquired somatically during cancer development
Cooke, S. L., Shlien, A., Marshall, J., Pipinikas, C., Martin, S., Tubío, J. M. C., Li, Y., Menzies, A. H., Mudie, L. J., Ramakrishna, M., et al. (2014) · Nature Communications · doi:10.1038/ncomms4644 · Cited by 106
Self-citationUnraveling the clonal hierarchy of somatic genomic aberrations
Prandi, D., Baca, S. C., Romanel, A., Barbieri, C. E., Mosquera, J., Fontugne, J., Beltran, H., Sboner, A., Garraway, L. A., Rubin, M. A., et al. (2014) · Genome biology · doi:10.1186/s13059-014-0439-6 · Cited by 102
Tellez-Gabriel, M., Knutsen, E., & Perander, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249457 · Cited by 108
Cancer genome-sequencing study design
Mwenifumbo, J. C., & Marra, M. A. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3445 · Cited by 104
Singel, S. M., Cornelius, C., Zaganjor, E., Batten, K. G., Sarode, V. R., Buckley, D. L., Peng, Y. S., John, G. B., Li, H. C., Sadeghi, N., et al. (2014) · Neoplasia · doi:10.1016/j.neo.2014.03.008 · Cited by 104
Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression
Warren, C. J., Westrich, J. A., Doorslaer, K. V., & Pyeon, D. (2017) · Viruses · doi:10.3390/v9080233 · Cited by 105
Whole-Genome Sequencing Reveals Breast Cancers with Mismatch Repair Deficiency
Davies, H., Morganella, S., Purdie, C. A., Jang, S. J., Borgen, E., Russnes, H., Glodzik, D., Zou, X., Viari, A., Richardson, A. L., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1083 · Cited by 99
Self-citationCharacterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomesPreprint
Dentro, S. C., Leshchiner, I., Haase, K., Tarabichi, M., Wintersinger, J. A., Deshwar, A. G., Yu, K., Rubanova, Y., Macintyre, G., Demeulemeester, J., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/312041 · Cited by 103
Self-citationChan, K., Sterling, J. F., Roberts, S. A., Bhagwat, A. S., Resnick, M. A., & Gordenin, D. A. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003149 · Cited by 103
Understanding genomic alterations in cancer genomes using an integrative network approach
Wang, E. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.11.050 · Cited by 100
Streppel, M. M., Lata, S., delaBastide, M., Montgomery, E. A., Wang, J. S., Canto, M. I., Macgregor-Das, A. M., Pai, S. I., Morsink, F. H. M., Offerhaus, G. J. A., et al. (2013) · Oncogene · doi:10.1038/onc.2012.586 · Cited by 98
Humphries, A., Cereser, B., Gay, L. J., Miller, D. S. J., Das, B., Gutteridge, A., Elia, G., Nye, E. L., Jeffery, R. E., Poulsom, R., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220353110 · Cited by 98
Singel, S. M., Cornelius, C., Batten, K. G., Fasciani, G., Wright, W. E., Lum, L., & Shay, J. W. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0082 · Cited by 99
Early Events in the Molecular Pathogenesis of Lung Cancer
Kadara, H. N., Scheet, P. A., Wistuba, I. I., & Spira, A. E. (2016) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0400 · Cited by 102
Molecular mechanism and clinical impact of APOBEC3B-catalyzed mutagenesis in breast cancer
Harris, R. S. (2015) · Breast Cancer Research · doi:10.1186/s13058-014-0498-3 · Cited by 98
Phylodynamics for cell biologists
Stadler, T., Pybus, O. G., & Stumpf, M. P. H. (2021) · Science · doi:10.1126/science.aah6266 · Cited by 91
Fumagalli, C., & Barberis, M. C. P. (2021) · Diagnostics · doi:10.3390/diagnostics11091555 · Cited by 97
Next-generation sequencing in breast cancer
Desmedt, C., Voet, T., Sotiriou, C. P., & Campbell, P. J. (2012) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328359554e · Cited by 96
Self-citationGuidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients
Capoluongo, E., Ellison, G., López‐Guerrero, J. A., Penault-Llorca, F. M., Ligtenberg, M. J. L., Banerjee, S. N., Singer, C. F., Friedman, E., Markiefka, B., Schirmacher, P., et al. (2017) · Seminars in Oncology · doi:10.1053/j.seminoncol.2017.08.004 · Cited by 96
Hirsch, T. Z., Pilet, J., Morcrette, G., Roehrig, A., Monteiro, B. J. E., Molina, L. M., Bayard, Q., Trépo, E., Meunier, L., Caruso, S., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1809 · Cited by 97
Breast Cancer Genomics From Microarrays to Massively Parallel Sequencing: Paradigms and New Insights
Ng, C. K. Y., Schultheis, A. M., Bidard, F., Weigelt, B., & Reis-Filho, J. S. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv015 · Cited by 96
Nikkilä, J., Kumar, R., Campbell, J., Brandsma, I., Pemberton, H. N., Wållberg, F., Nagy, K., Scheer, I., Vértessy, B. G., Serebrenik, A. A., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.133 · Cited by 94
Yeh, P. S.-H., Hunter, T., Sinha, D., Ftouni, S., Wallach, E., Jiang, D. H. S., Chan, Y.-C., Wong, S. Q., Silva, M. J., Vedururu, R., et al. (2017) · Nature Communications · doi:10.1038/ncomms14756 · Cited by 93
Reliability of Whole-Exome Sequencing for Assessing Intratumor Genetic Heterogeneity
Shi, W., Ng, C. K. Y., Lim, R. S., Jiang, T., Kumar, S., Li, X., Wali, V. B., Piscuoglio, S., Gerstein, M., Chagpar, A. B., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.10.046 · Cited by 92
A community effort to create standards for evaluating tumor subclonal reconstruction
Participants, D. S.-H., Salcedo, A., Tarabichi, M., Espiritu, S. M. G., Deshwar, A. G., David, M., Wilson, N. M., Dentro, S. C., Wintersinger, J. A., Liu, L., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-019-0364-z · Cited by 84
Self-citationGenetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma
Thomas, N., Dreval, K., Gerhard, D. S., Hilton, L. K., Abramson, J. S., Ambinder, R. F., Barta, S. K., Bartlett, N. L., Bethony, J. M., Bhatia, K. G., et al. (2022) · Blood · doi:10.1182/blood.2022016534 · Cited by 91
Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia
Klintman, J., Appleby, N., Stamatopoulos, B., Ridout, K., Eyre, T. A., Robbe, P., Pascua, L. L., Knight, S. J. L., Dreau, H. M.-P., Cabes, M., et al. (2020) · Blood · doi:10.1182/blood.2020005650 · Cited by 92
Liu, C., Srihari, S., Cao, K. L., Chenevix‐Trench, G., Simpson, P. T., Ragan, M. A., & Khanna, K. K. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku284 · Cited by 91
Genetic and Non-Genetic Mechanisms Underlying Cancer Evolution
Shlyakhtina, Y., Moran, K. L., & Portal, M. M. (2021) · Cancers · doi:10.3390/cancers13061380 · Cited by 91
Parallel evolution of tumour subclones mimics diversity between tumours
Martinez, P., Birkbak, N. J., Gerlinger, M., McGranahan, N., Burrell, R. A., Rowan, A., Joshi, T., Fisher, R. A., Larkin, J., Szállási, Z., et al. (2013) · The Journal of Pathology · doi:10.1002/path.4214 · Cited by 88
Selli, Ç., Dixon, J. M., & Sims, A. H. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0779-0 · Cited by 86
Shinde, J., Bayard, Q., Imbeaud, S., Hirsch, T. Z., Liu, F., Renault, V., Zucman‐Rossi, J., & Letouzé, É. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty388 · Cited by 86
Khabirova, E., Jardine, L., Coorens, T. H. H., Webb, S., Treger, T. D., Engelbert, J., Porter, T., Prigmore, E., Collord, G., Piapi, A., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01720-7 · Cited by 89
Evolving concepts of tumor heterogeneity
Zellmer, V. R., & Zhang, S. (2014) · Cell & Bioscience · doi:10.1186/2045-3701-4-69 · Cited by 91
Translating insights into tumor evolution to clinical practice: promises and challenges
Fittall, M. W., & Loo, P. V. (2019) · Genome Medicine · doi:10.1186/s13073-019-0632-z · Cited by 91
Dayton, T. L., Alcala, N., Moonen, L., den Hartigh, L., Geurts, V., Mangiante, L., Lap, L. M. V., Dost, A. F. M., Beumer, J., Levy, S., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.11.007 · Cited by 89
Geographic variation of mutagenic exposures in kidney cancer genomes
Senkin, S., Moody, S., Díaz‐Gay, M., Abedi‐Ardekani, B., Cattiaux, T., Ferreiro-Iglesias, A., Wang, J., Fitzgerald, S., Kazachkova, M., Vangara, R., et al. (2024) · Nature · doi:10.1038/s41586-024-07368-2 · Cited by 95
Self-citationNew paradigms in clonal evolution: punctuated equilibrium in cancer
Cross, W. C. H., Graham, T. A., & Wright, N. A. (2016) · The Journal of Pathology · doi:10.1002/path.4757 · Cited by 88
Chemokines in triple-negative breast cancer heterogeneity: New challenges for clinical implications
Mehraj, U., Mushtaq, U., Mir, M. A., Saleem, A., Macha, M. A., Lone, M. N., Hamid, A., Zargar, M. A., Ahmad, S. M., & Wani, N. A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.008 · Cited by 88
The role of DNA damage repair (DDR) system in response to immune checkpoint inhibitor (ICI) therapy
Shi, C., Qin, K., Lin, A., Jiang, A., Cheng, Q., Liu, Z., Zhang, J., & Luo, P. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02469-0 · Cited by 85
Prognostic and predictive values of long non-coding RNA LINC00472 in breast cancer
Shen, Y., Katsaros, D., Loo, L. W. M., Hernandez, B. Y., Chong, C. D. K., Canuto, E. M., Biglia, N., Lu, L., Risch, H. A., Chu, W., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3287 · Cited by 87
Somatic mutations and single-cell transcriptomes reveal the root of malignant rhabdoid tumours
Custers, L., Khabirova, E., Coorens, T. H. H., Oliver, T. R. W., Calandrini, C., Young, M. D., Braga, F. A. V., Ellis, P., Mamanova, L., Segers, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21675-6 · Cited by 84
Evolutionary histories of breast cancer and related clones
Nishimura, T., Kakiuchi, N., Yoshida, K., Sakurai, T., Kataoka, T. R., Kondoh, E., Chigusa, Y., Kawai, M., Sawada, M., Inoue, T., et al. (2023) · Nature · doi:10.1038/s41586-023-06333-9 · Cited by 85
Intratumor heterogeneity: Nature and biological significance
Gerashchenko, T. S., Denisov, E. V., Литвяков, Н. В., Zavyalova, M. V., Vtorushin, S. V., Tsyganov, M. M., Михайлович, П. В., & Чердынцева, Н. В. (2013) · Biochemistry (Moscow) · doi:10.1134/s0006297913110011 · Cited by 86
The challenge of intratumour heterogeneity in precision medicine
Seoane, J., & Mattos‐Arruda, L. D. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12240 · Cited by 85
Mangiante, L., Alcala, N., Sexton‐Oates, A., Genova, A. D., González-Pérez, A., Khandekar, A., Bergstrom, E. N., Kim, J., Liu, X., Blázquez‐Encinas, R., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01321-1 · Cited by 89
Self-citationChkhaidze, K., Heide, T., Werner, B., Williams, M. J., Huang, W., Caravagna, G., Graham, T. A., & Sottoriva, A. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007243 · Cited by 79
Timing somatic events in the evolution of cancer
Jolly, C., & Loo, P. V. (2018) · Genome biology · doi:10.1186/s13059-018-1476-3 · Cited by 86
Signatures of TOP1 transcription-associated mutagenesis in cancer and germline
Reijns, M. A. M., Parry, D. A., Williams, T., Nadeu, F., Hindshaw, R. L., Rios-Szwed, D. O., Nicholson, M. D., Carroll, P., Boyle, S., Royo, R., et al. (2022) · Nature · doi:10.1038/s41586-022-04403-y · Cited by 83
Self-citationBiallelic DICER1 Mutations in Sporadic Pleuropulmonary Blastoma
Seki, M., Yoshida, K., Shiraishi, Y., Shimamura, T., Sato, Y., Nishimura, R., Okuno, Y., Chiba, K., Tanaka, H., Kato, K., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2470 · Cited by 82
Estrogen receptor (ER) α mutations in breast cancer: hidden in plain sight
Fuqua, S. A. W., Gu, G., & Rechoum, Y. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-2847-4 · Cited by 83
Uncovering the genomic heterogeneity of multifocal breast cancer
Desmedt, C., Fumagalli, D., Pietri, E., Zoppoli, G. M., Brown, D. N., Nik‐Zainal, S., Gundem, G., Rothé, F., Majjaj, S., Garuti, A., et al. (2015) · The Journal of Pathology · doi:10.1002/path.4540 · Cited by 82
Self-citationGenome evolution in ductal carcinoma in situ: invasion of the clones
Casasent, T. D., Edgerton, M. E., & Navin, N. E. (2016) · The Journal of Pathology · doi:10.1002/path.4840 · Cited by 84
Guo, L., Yi, X., Chen, L., Zhang, T., Guo, H., Chen, Z., Cheng, J., Cao, Q., Liu, H., Hou, C., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.08.052 · Cited by 83
Genomic signature of Fanconi anaemia DNA repair pathway deficiency in cancer
Webster, A., Sanders, M. A., Patel, K., Dietrich, R., Noonan, R. J., Lach, F. P., White, R. R., Goldfarb, A. M., Hadi, K., Edwards, M. M., et al. (2022) · Nature · doi:10.1038/s41586-022-05253-4 · Cited by 96
Self-citationCancer stem cells as ‘units of selection’
Greaves, M. F. (2012) · Evolutionary Applications · doi:10.1111/eva.12017 · Cited by 85
A general framework for analyzing tumor subclonality using SNP array and DNA sequencing data
Li, B., & Li, J. Z. (2014) · Genome biology · doi:10.1186/s13059-014-0473-4 · Cited by 76
Chromosome instability drives phenotypic switching to metastasis
Gao, C., Su, Y., Koeman, J. M., Haak, E. A., Dykema, K. J., Essenberg, C., Hudson, E., Petillo, D., Khoo, S. K., & Woude, G. F. V. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618215113 · Cited by 79
Leshchiner, I., Livitz, D. G., Gainor, J. F., Rosebrock, D., Spiro, O., Martinez, A. Z., Mroz, E. A., Lin, J. J., Stewart, C., Kim, J., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/508127 · Cited by 76
Breast cancer intratumour heterogeneity: current status and clinical implications
Joseph, C., Papadaki, A., Althobiti, M. M., Alsaleem, M. A., Aleskandarany, M. A., & Rakha, E. A. (2018) · Histopathology · doi:10.1111/his.13642 · Cited by 79
Copy-number analysis and inference of subclonal populations in cancer genomes using Sclust
Cun, Y., Yang, T.-P., Achter, V., Lang, U., & Peifer, M. (2018) · Nature Protocols · doi:10.1038/nprot.2018.033 · Cited by 78
David, S., Tan, J., Savas, P. S., Bressel, M., Kelly, D., Foroudi, F., Loi, S., & Siva, S. (2019) · The Breast · doi:10.1016/j.breast.2019.10.016 · Cited by 77
Brioli, A., Giles, H. V., Pawlyn, C., Campbell, J. P., Kaiser, M., Melchor, L., Jackson, G. H., Gregory, W. M., Owen, R. G., Child, J. A., et al. (2014) · Blood · doi:10.1182/blood-2013-12-542662 · Cited by 76
Wang, E., Zou, J., Zaman, N., Beitel, L. K., Trifiro, M. A., & Paliouras, M. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.06.002 · Cited by 78
Genomic evidence supports a clonal diaspora model for metastases of esophageal adenocarcinoma
Noorani, A., Li, X., Goddard, M. J., Crawte, J., Alexandrov, L. B., Secrier, M., Eldridge, M., Bower, L., Weaver, J. M. J., Lao-Sirieix, P., et al. (2020) · Nature Genetics · doi:10.1038/s41588-019-0551-3 · Cited by 75
Self-citationMeasuring Clonal Evolution in Cancer with Genomics
Williams, M. J., Sottoriva, A., & Graham, T. A. (2019) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-083117-021712 · Cited by 83
Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers
Shukla, N. N., Levine, M. F., Gundem, G., Domenico, D., Spitzer, B. G., Bouvier, N., Ossa, J. A., Głodzik, D., Medina-Martinez, J. S., Bhanot, U. K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30233-7 · Cited by 70
Self-citationClonality and Evolutionary History of Rhabdomyosarcoma
Chen, L., Shern, J. F., Wei, J. S., Yohe, M. E., Song, Y., Hurd, L., Liao, H., Catchpoole, D. R., Skapek, S. X., Barr, F. G., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005075 · Cited by 77
Advances for studying clonal evolution in cancer
Ding, L., Raphael, B. J., Chen, F., & Wendl, M. C. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.12.028 · Cited by 74
Aberrations in DNA repair pathways in cancer and therapeutic significances
Motegi, A., Masutani, M., Yoshioka, K., & Bessho, T. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.02.005 · Cited by 76
The landscape of drug sensitivity and resistance in sarcoma
Shihabi, A. A., Tebon, P. J., Nguyen, H. T. L., Chantharasamee, J., Sartini, S., Davarifar, A., Jensen, A. Y., Diaz-Infante, M. B., Cox, H., Gonzalez, A. E., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.08.010 · Cited by 79
Breast cancer intratumor genetic heterogeneity: causes and implications
Ng, C. K. Y., Pemberton, H. N., & Reis-Filho, J. S. (2012) · Expert Review of Anticancer Therapy · doi:10.1586/era.12.85 · Cited by 77
Tracing the origin of disseminated tumor cells in breast cancer using single-cell sequencing
Demeulemeester, J., Kumar, P., Møller, E. K., Nord, S., Wedge, D. C., Peterson, A., Mathiesen, R. R., Fjelldal, R., Esteki, M. Z., Theunis, K., et al. (2016) · Genome biology · doi:10.1016/s0959-8049(16)61063-8 · Cited by 77
Self-citationIntratumoral Heterogeneity in a Trp53 -Null Mouse Model of Human Breast Cancer
Zhang, M., Tsimelzon, A. I., Chang, C.-H., Fan, C., Wolff, A., Perou, C. M., Hilsenbeck, S. G., & Rosen, J. M. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-1101 · Cited by 76
Genome Sequencing during a Patient’s Journey through Cancer
Nangalia, J., & Campbell, P. J. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1910138 · Cited by 66
Self-citationA glycolytic metabolite bypasses “two-hit” tumor suppression by BRCA2
Kong, L. R., Gupta, K., Wu, A., Perera, D., Iványi-Nagy, R., Ahmed, S. M., Tan, T. Z., Tan, S. L.-W., Fuddin, A., Sundaramoorthy, E., et al. (2024) · Cell · doi:10.1016/j.cell.2024.03.006 · Cited by 74
du Manoir, S., Orsetti, B., Bras-Gonçalves, R., Nguyen, T.-T., Lasorsa, L., Boissière‐Michot, F., Massemin, B., Colombo, P., Bibeau, F., Jacot, W., et al. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.11.010 · Cited by 69
Sonnenschein, C., Soto, A. M., Rangarajan, A., & Kulkarni, P. (2014) · Journal of Biosciences · doi:10.1007/s12038-013-9403-y · Cited by 72
Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape
Kader, T., Hill, P., Rakha, E. A., Campbell, I., & Gorringe, K. L. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-0967-1 · Cited by 72
Accelerated single cell seeding in relapsed multiple myeloma
Landau, H. J., Yellapantula, V. D., Diamond, B. T., Rustad, E. H., Maclachlan, K. H., Gundem, G., Medina-Martinez, J. S., Ossa, J. A., Levine, M. F., Zhou, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17459-z · Cited by 72
Self-citationComputational immunogenomic approaches to predict response to cancer immunotherapies
Addala, V., Newell, F., Pearson, J. V., Redwood, A., Robinson, B. W. S., Creaney, J., & Waddell, N. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00830-6 · Cited by 79
Metadata
- Authors
- Nik-Zainal, S., Van Loo, P., Wedge, D. C., Alexandrov, L. B., Greenman, C. D., Lau, K. W., Raine, K., Jones, D., Marshall, J., Ramakrishna, M., Shlien, A., Cooke, S. L., Hinton, J., Menzies, A., Stebbings, L. A., Leroy, C., Jia, M., Rance, R., Mudie, L. J., Gamble, S. J., Stephens, P. J., McLaren, S., Tarpey, P. S., Papaemmanuil, E., Davies, H. R., Varela, I., McBride, D. J., Bignell, G. R., Leung, K., Butler, A. P., Teague, J. W., Martin, S., Jönsson, G., Mariani, O., Boyault, S., Miron, P., Fatima, A., Langerød, A., Aparicio, S. A. J. R., Tutt, A., Sieuwerts, A. M., Borg, Å., Thomas, G., Salomon, A. V., Richardson, A. L., Børresen-Dale, A.-L., Futreal, P. A., Stratton, M. R., & Campbell, P. J.
- Affiliations
- Wellcome Sanger Institute (GB)
- University of East Anglia (GB)
- King's College London (GB)
- Institut Curie (FR)
- Lyon 1 Université (FR)
- Dana-Farber Cancer Institute (US)
- Oslo University Hospital (NO)
- University of British Columbia (CA)
- Erasmus MC (NL)
- Lund University (SE)
- Brigham and Women's Hospital (US)
- University of Cambridge (GB)
- Corresponding author
- Campbell, Peter J.
- ORCID
- Wedge, David C.
- Alexandrov, Ludmil B.
- Lau, King Wai
- Raine, Keiran
- Jones, David
- Marshall, John
- Ramakrishna, Manasa
- Shlien, Adam
- Hinton, Jonathan
- Menzies, Andrew
- Jia, Mingming
- Tarpey, Patrick S.
- Papaemmanuil, Elli
- Davies, Helen R.
- Varela, Ignacio
- McBride, David J.
- Teague, Jon W.
- Martin, Sancha
- Jönsson, Goran
- Mariani, Odette
- Boyault, Sandrine
- Miron, Penelope
- Aparicio, Samuel A.J.R.
- Tutt, Andrew
- Sieuwerts, Anieta M.
- Borg, Åke
- Thomas, Gilles
- Richardson, Andrea L.
- Futreal, P. Andrew
- Stratton, Michael R.
- Campbell, Peter J.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2012-05
- Volume
- 149
- Issue
- 5
- Pages
- 994-1007
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC3428864
- OpenAlex
- W2109991075
- Cited by
- 1,443
- References
- 39
- Citations by year
- 2026: 51 · 2025: 77 · 2024: 83 · 2023: 84 · 2022: 71 · 2021: 112 · 2020: 105 · 2019: 93 · 2018: 114 · 2017: 103 · 2016: 100 · 2015: 126 · 2014: 139 · 2013: 140 · 2012: 44
- FWCI
- 47.68
- Type
- journal article
- Language
- en
- Update notices
- erratum (2015-08-13)
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Cell (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- UEA Digital Repository (University of East Anglia) (acceptedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Lirias (KU Leuven) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- Wellcome Trust (088340, 093867, WT088340MA, 098051)
- National Institute for Health and Care Research
- European Commission (242006)
- National Cancer Institute (CA 089393, P50CA089393)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Keywords
- breast cancer, tumor evolution, clonal evolution, somatic mutations, mutational processes, clonal expansion, cancer genomics
- MeSH terms
- Algorithms, Breast Neoplasms, Cell Transformation, Neoplastic, Chromosome Aberrations, Female, Humans, Mutation, Point Mutation, Clonal Evolution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
